神经内分泌肿瘤的分子影像学
本文为小型综述,概述神经内分泌肿瘤(NEN)分子影像的主要模态:生长抑素受体靶向显像(含拮抗剂)、18F-DOPA、GLP-1受体显像、MIBG及CXCR4等,并展望成纤维细胞活化蛋白、GIP受体和CCK-2受体等新靶点。
要点
- 生长抑素受体是NEN细胞最常表达的激素受体,可用多种放射性生长抑素类似物及拮抗剂进行分子影像。
- 18F-DOPA显像已成为NEN的二线影像模态,但晚期甲状腺髓样癌评估除外。
- GLP-1受体显像已成为定位常较小胰岛素瘤的新标准。
核心结论
- 分子影像的关键是使用兼具放射性成分和功能成分的放射性示踪剂,功能成分靶向肿瘤特定特征,放射性成分使靶点可见。
研究设计与样本
- 本文为小型综述,旨在概述神经内分泌肿瘤领域目前使用的主要分子影像模态,并提供未来发展的展望。
主要发现
- NEN细胞最常表达的激素受体是生长抑素受体,可用多种放射性生长抑素类似物及生长抑素拮抗剂靶向显像,后者已显示改善的影像质量。
- 18F-DOPA显像已成为NEN的二线影像模态,但晚期甲状腺髓样癌的评估除外。
- 对于因分化差而生长抑素受体表达不足的NEN,替代方案包括靶向葡萄糖代谢,该法也可用于预后判断。
- 对于常较小胰岛素瘤的定位,胰高血糖素样肽-1(GLP-1)受体显像已成为新标准。
- 其他替代方案包括间碘苄胍和分子靶点C-X-C趋化因子受体-4;靶向成纤维细胞活化蛋白、葡萄糖依赖性促胰岛素多肽受体和胆囊收缩素-2受体的新放射性肽已在NEN中被识别,尚待进一步评估。
局限性
- 靶向成纤维细胞活化蛋白、葡萄糖依赖性促胰岛素多肽受体和胆囊收缩素-2受体的新放射性肽已在NEN中被识别,尚待进一步评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The key for molecular imaging is the use of a radiotracer with a radioactive and a functional component. While the functional component targets a specific feature of the tumor, the radioactive component makes the target visible. Neuroendocrine neoplasms (NEN) are a diverse group of rare tumors that arise from neuroendocrine cells found mainly in the gastroenteropancreatic system, lung, thyroid, and adrenal glands. They are characterized by the expression of specific hormone receptors on the tumor cell surface, which makes them ideal targets for radiolabeled peptides. The most commonly expressed hormone receptors on NEN cells are the somatostatin receptors. They can be targeted for molecular imaging with various radiolabeled somatostatin analogs, but also with somatostatin antagonists, which have shown improved imaging quality. 18F-DOPA imaging has become a second-line imaging modality in NENs, with the exception of the evaluation of advanced medullary thyroid carcinoma. Alternatives for NENs with insufficient somatostatin receptor expression due to poor differentiation involve targeting glucose metabolism, which can also be used for prognosis. For the localization of the often-small insulinoma, glucagon-like peptide-1 (GLP-1) receptor imaging has become the new standard. Other alternatives involve metaiodobenzylguanidine and the molecular target C-X-C motif chemokine receptor-4. In addition, new radiopeptides targeting the fibroblast activation protein, the glucose-dependent insulinotropic polypeptide receptor and cholecystokinin-2 receptors have been identified in NENs and await further evaluation. This mini-review aims to provide an overview of the major molecular imaging modalities currently used in the field of NENs, and also to provide an outlook on future developments.
引用
- Refardt J, Hofland J, Wild D, et al. Molecular Imaging of Neuroendocrine Neoplasms. J Clin Endocrinol Metab. 2022. PMID: 35380158. doi:10.1210/clinem/dgac207
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。